Clinical Red Flags Before the Day of Ingestion: Why an Experienced Team Matters
- Quietus

- Jul 19
- 6 min read

Most of the public conversation about medical aid in dying focuses on legality, ethics, and the requirements of the law. Those issues matter, but there is also a very important clinical dimension that families rarely hear about until they are far along in the aid in dying process: whether the medication will actually work the way everyone expects on the day it is taken.
A peaceful death is the goal, and in the large majority of cases it is what happens. But it is not automatic. It depends on clinical factors that have to be identified and managed in the days and weeks before ingestion, not discovered on the day itself, when it is too late to adjust. This is the single strongest argument for having an experienced clinical team involved from the first conversation to the last: not because the process is dangerous, but because the difference between a peaceful, planned death and a distressing one often comes down to details that only a trained eye catches in advance.
This post walks through the clinical red flags that an experienced team watches for, and why catching them early is the whole point.
What “red flags” means here
A red flag is not a disqualification. It is a signal that something needs attention before proceeding; a reason to adjust the plan, change the pre-medication, reconsider the timing, or prepare differently. Every red flag below has a clinical response. The problem is not the red flag itself; the problem is a red flag that goes unnoticed because no one with the right training was looking.
The published data make the case plainly. Studies of oral aid in dying medication have documented complications including prolonged time to death, vomiting, regurgitation, and, rarely, patients regaining consciousness. Reported complication rates in some datasets have run into the low double digits. Nearly all of these are foreseeable and, with the right preparation, preventable or manageable. Foreseeing them is a clinical skill.
Red flag 1: A high risk of nausea and vomiting
The medications used in aid in dying are bitter and hard on the stomach. If a patient vomits after ingesting, the death may be incomplete or prolonged, and the experience distressing for everyone present. This is why a pre-medication anti-nausea protocol is standard, typically given hours before the main medication, not alongside it.
The red flags an experienced clinician looks for are the things that raise vomiting risk above baseline: active nausea in the days prior, a history of severe treatment-related nausea, gastroparesis, or certain cancers and their treatments. Each changes what the anti-emetic plan should look like. A generic protocol applied to a high-risk patient is a preventable problem waiting to happen.
Red flag 2: Absorption and gastrointestinal problems
The medication has to be absorbed through the gastrointestinal tract to work. Anything that interferes with absorption is a serious clinical concern that must be assessed in advance. That includes bowel obstruction, significant delayed gastric emptying, short-gut or malabsorption syndromes, severe dehydration, and certain abdominal cancers. A patient who has eaten recently may also absorb the medication more slowly, which is why fasting guidance is part of the plan.
None of these are visible on a legal form. They surface only when someone reviews the patient's actual clinical picture, the diagnosis, the imaging, the medication list, the recent history, with aid in dying specifically in mind. This is a different review than routine oncology or hospice care provides.
Red flag 3: Opioid and benzodiazepine tolerance
This is one of the most important and most overlooked. Many terminally ill patients have been on opioids and benzodiazepines for a long time, at escalating doses, and have developed substantial tolerance. Because aid in dying protocols rely on sedative components, a patient with high tolerance may not respond as expected to a standard preparation, which can mean a longer time to sleep, or to death.
Experienced prescribers know to flag opioid and benzodiazepine tolerance early and to adjust the approach for high-risk patients. A clinician who does not routinely do this work may not think to ask. The patient's long medication history, which looks like ordinary palliative care, is in this context a clinical variable that changes the plan.
Red flag 4: A narrowing ability to self-administer
New York law requires that the patient take the medication themselves. This is absolute. But self-administration is not just swallowing a pill; it typically means ingesting a full volume of liquid, without help, within a short window, and keeping it down. Conditions that affect swallowing, hand strength, or alertness can quietly erode a patient's ability to do this.
The red flag is a declining capacity to self-administer; a trajectory, not just a snapshot. A patient who can manage it comfortably today may not be able to in three weeks. An experienced team tracks that curve and helps the patient and family understand the window they are actually working with, so the decision is not overtaken by the disease. This is one of the reasons beginning the process early matters so much.
Red flag 5: Changes in decision-making capacity
Capacity is required not only at each request but at the moment of ingestion. Some terminal conditions — brain metastases, hepatic or renal failure, certain medications — can cause fluctuating or declining cognition. A patient who clearly had capacity at the time of the written request may lose capacity weeks later.
This is not about second-guessing a patient's wishes. It is about making sure the person taking the medication understands, in that moment, what they are doing and is doing it voluntarily. New York already builds in a mandatory capacity evaluation for every patient. An experienced team continues to watch for capacity changes right up to the day, because the law requires it and because it protects the patient.
Red flag 6: The medication logistics themselves
Finally, there are the practical red flags that have nothing to do with the patient's body and everything to do with the system around them. Has a participating pharmacy actually been identified? Most retail pharmacies will not fill these prescriptions. Has the medication been stored and prepared correctly? Will a knowledgeable clinician be reachable on the day if something looks off? A gap in any of these is a red flag that has caused avoidable distress in cases where no one was coordinating the whole chain.
Why an experienced clinical team changes the outcome
Read the list again and a pattern emerges: almost none of these red flags appear on the legal paperwork, and almost all of them are invisible unless someone is specifically looking for them, in advance, with aid in dying in mind. That is what an experienced clinical team provides that a well-meaning but unfamiliar clinician or attendant cannot.
An experienced team does three things that matter here. It anticipates — reviewing the full clinical picture for the specific factors that affect this medication, not just general prognosis. It adjusts — tailoring the anti-emetic plan, the timing, and the approach to the individual patient rather than applying a one-size protocol. And it stays present, following the patient through the waiting period and up to the day, so that a change in the patient's condition is caught while there is still time to respond.
The families who have the hardest experiences are almost never the ones who did something wrong. They are the ones who were left to assemble the process themselves, from clinicians who were willing but inexperienced, with no one watching the clinical picture as a whole. A good death on the day is built in the weeks before it — quietly, by people who know what to look for.
How Quiĕtus helps
Quiĕtus is a care coordination service, and this is precisely the work we exist to do. We connect patients with clinicians experienced in aid in dying, make sure the full clinical picture is reviewed for the red flags above, coordinate the anti-emetic and timing plan, confirm a participating pharmacy well in advance, and stay involved through the waiting period and the day itself. Families should not be left to catch clinical red flags on their own, at the hardest moment of their lives.
If you or someone you love is considering medical aid in dying in New York and wants an experienced team involved from the start, contact us. A first conversation commits you to nothing.
This post was reviewed and verified by Daniel Cogan, NP




Comments